{"id":56874,"name":"KARUNA THERAPEUTICS, INC.","slug":"karuna-therapeutics-inc","state":"MA","country":"United States of America","description":"Clinical-stage biopharmaceutical company","totalSpending":200000,"filings":5,"yearlySpending":[{"year":2023,"income":100000},{"year":2024,"income":100000}],"issues":[{"code":"HCR","display":"Health Issues"}],"firms":["AVENUE SOLUTIONS"],"lobbyists":["ELIZABETH BARNETT","TRACY SPICER"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Education around innovation in schizophrenia","Education around innovation in schizophrenia","Education around innovation in schizophrenia; Issues related to mental health; Expiring healthcare extenders","Education around innovation in schizophrenia; Issues related to mental health; Expiring healthcare extenders; H.R. 4366, the Consolidated Appropriations Act, 2024 (P.L. 118-42); H.R. 2882, the Further"]}